Stock RP REPLICEL LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Quotes RepliCel Life Sciences Inc. Toronto S.E.

Equities

RP

CA76027P4006

Biotechnology & Medical Research

Delayed Toronto S.E.
Other stock markets
 11:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
0.055 CAD -.--% Intraday chart for RepliCel Life Sciences Inc. -21.43% -15.38%
May. 31 RepliCel Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 17 RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Performance

6 months-8.33%
Current year-15.38%
1 year-67.65%
3 years-86.59%
5 years-81.67%
10 years-99.10%

Volumes

markets
Daily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
24 966
Daily volume ratio
0.00
Avg. Volume 20 sessions CAD
1 373.13
Avg. Volume 20 sessions USD
1 006.50
Record volume 1
1 301 647
Record volume 2
1 165 052
Record volume 3
832 602
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (CAD)
3 798 555
Capitalization (USD)
2 784 341
Net sales (CAD)
353 735
Net sales (USD)
259 288
Number of employees
1
Sales / Employee (CAD)
353 735
Sales / Employee (USD)
259 288
Free-Float
39.48 %
Free-Float capitalization (CAD)
1 417 112
Free-Float capitalization (USD)
1 038 743
Average Daily Capital Traded
0.04%

Highs and lows

Current year
0.05
Extreme 0.05
0.07
1 year
0.04
Extreme 0.04
0.18
3 years
0.04
Extreme 0.04
0.42
5 years
0.00
Extreme 0
0.58
10 years
0.00
Extreme 0
7.20

Indicators

Moving average 5 days
0.06
Moving average 20 days
0.06
Moving average 50 days
0.08
Moving average 100 days
0.13
Price spread / (MMA5)
+9.09%
Price spread / (MMA20)
+9.09%
Price spread / (MMA50)
+45.45%
Price spread / (MMA100)
+136.36%
STIM
RSI 9 days
45.42
RSI 14 days
45.21

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
REPLICEL LIFE SCIENCES INC. Stock RepliCel Life Sciences Inc.
-.--%-21.43%-15.38%-67.65% 2.78M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.69%+2.99%+20.12%+41.23% 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.83%+6.36%+25.25%+53.12% 119B
ARGENX SE Stock argenx SE
+0.33%+7.10%+25.56%+27.45% 27.95B
BIONTECH SE Stock BioNTech SE
+0.30%+6.07%-19.51%-22.06% 20.5B
GENMAB A/S Stock Genmab A/S
+2.64%+5.16%-14.36%-28.39% 17.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
+1.11%+3.49%-15.63%-20.77% 16.1B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-0.05%+2.05%-46.67%-38.80% 14.97B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.63%+6.00%+11.89%+51.63% 14.84B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
0.00%+0.25%+57.74%+40.86% 14.38B
INSMED INCORPORATED Stock Insmed Incorporated
-0.42%+9.59%+147.53%+277.70% 12.37B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
+12.10%+17.43%-9.64%-21.92% 9.91B
ZEALAND PHARMA A/S Stock Zealand Pharma A/S
-0.32%-2.58%+147.72%+301.96% 9.55B
VAXCYTE, INC. Stock Vaxcyte, Inc.
+0.52%+5.91%+31.19%+72.11% 8.96B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
+1.75%+1.67%+9.63%+59.52% 7.92B
CEREVEL THERAPEUTICS HOLDINGS, INC. Stock Cerevel Therapeutics Holdings, Inc.
-1.80%-1.59%-4.93%+32.60% 7.34B
Average+1.12%+4.87%+21.91%+47.41%
Weighted average by Cap.+0.78%+4.91%+21.37%+45.06%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Chart RepliCel Life Sciences Inc.

Chart RepliCel Life Sciences Inc.
More charts

Monthly variations

Annual change

2024-15.38%
2023-23.53%
2022-63.04%
2021-.--%
2020-9.80%
2019-31.08%
2018-7.50%
2017-57.89%
2016-62.75%
2015-31.08%
2014-56.47%
  1. Stock Market
  2. Equities
  3. REPCF Stock
  4. RP Stock
  5. Quotes RepliCel Life Sciences Inc.